Global Anti Malarial Drugs Market Share

Statistics for the 2023 & 2024 Global Anti Malarial Drugs market share, created by Mordor Intelligence™ Industry Reports. Global Anti Malarial Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Anti Malarial Drugs Industry

The majority of the anti-malarial drug is being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. These global players are mostly based in developed countries like the United States, the United Kingdom, France, Germany, and Japan. Asia-pacific is also witnessing the emergence of some small players which has helped the market growth and increased its competitiveness. Some of the major players in the market include, Cipla, GlaxoSmithKline PLC, Novartis AG, Strides Pharma Science Limited, Glenmark Pharmaceuticals, Bayer AG, Alvizia Healthcare, among others. 

Anti Malarial Drugs Market Leaders

  1. Cipla

  2. Novartis AG

  3. Strides Pharma Science Limited

  4. Glenmark Pharmaceuticals

  5. GlaxoSmithKline PLC

*Disclaimer: Major Players sorted in no particular order

Anti-Malarial Drugs Market Concentration

Anti-Malarial Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)